NXNASXNexsen Limited

NXN price activity

Last Price

Change (24hr)

AUD (%)

Volume

Volume (4w avg)

Previous Close

N/A

Last Trade

NXN price performance

-1.25%

-10.57%

48.12%

YTD

-15.36%

NXN price fundamentals

N/A

Shares Issued

N/A

Earnings Per Share (EPS)

N/A

Dividends Per Share (DPS)

N/A

P/E Ratio

Price market cap

Market cap

N/A

AU-ASX rank

N/A

Sector Rank

N/A

NXN details

View company website

View AU-ASX Official Page

NXN Market Signals

More ways to discover

Browse Australia news Discover ASX signals Browse all ASX stocks

Nexsen Limited (AU-ASX: NXN)

Nexsen Limited operates as a nanobiotechnology company that develops proprietary biosensing platforms for rapid, high-precision point-of-care (POC) medical diagnostics and point-of-use sensing for veterinary, agricultural, and biosecurity applications. The company offers Group B Streptococcus (GBS) rapid sensor, a diagnostic for the detection of human GBS in expectant mothers; kidney diseases, a POC tests for the screening, detection, and ongoing monitoring of various subsets of acute kidney injury and chronic kidney disease; bovine mastitis, a farm diagnostic to detect mastitis early which helps farmers; biosecurity pathogen tests, a portable sensor for frontline detection of invasive pests and pathogens -built for customs officers, farmers, and quarantine zones. The company was incorporated in 2021 and is based in Sydney, Australia.

Price: A$0.24

Sector: Healthcare — Biotechnology